Suppr超能文献

利用功能化多聚 ADP-核糖聚合物合成双特异性抗体偶联物。

Synthesis of Bispecific Antibody Conjugates Using Functionalized Poly-ADP-ribose Polymers.

机构信息

Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, California 90089, United States.

Department of Chemistry, Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, California 90089, United States.

出版信息

Biochemistry. 2023 Mar 21;62(6):1138-1144. doi: 10.1021/acs.biochem.2c00718. Epub 2023 Feb 23.

Abstract

Poly-ADP-ribose (PAR) is a natural type of polymer derived from enzymatic reactions catalyzed by cellular poly(ADP-ribose) polymerases (PARPs). Given its notable solubility and biocompatibility, the PAR polymer may function as effective carriers for therapeutics in addition to modulating biomolecular interactions in cells. To explore its therapeutic potential, we herein developed a PAR polymer-based bispecific antibody targeting both human epidermal growth factor receptor 2 (HER2) and T-cell CD3 antigens. This was accomplished by conjugating anti-HER2 and anti-CD3 monoclonal antibodies to azido-functionalized PAR polymers through click chemistry. The generated PAR polymer-anti-HER2/anti-CD3 antibody conjugate could not only bind specifically to both HER2- and CD3-expressing target cells but also display potent cytotoxicity against HER2-positive breast cancer cells in the presence of non-activated human peripheral blood mononuclear cells (PBMCs). Functionalized PAR polymers provide a new strategy for synthesizing bispecific antibodies and may enable generation of PAR polymer-based conjugates with unique pharmacological activities for biomedical applications.

摘要

聚 ADP-核糖 (PAR) 是一种天然类型的聚合物,由细胞多聚 ADP-核糖聚合酶 (PARPs) 催化的酶促反应衍生而来。鉴于其显著的水溶性和生物相容性,PAR 聚合物除了可以调节细胞内生物分子相互作用外,还可能作为治疗药物的有效载体。为了探索其治疗潜力,我们开发了一种基于 PAR 聚合物的双特异性抗体,该抗体靶向人表皮生长因子受体 2 (HER2) 和 T 细胞 CD3 抗原。这是通过点击化学将抗 HER2 和抗 CD3 单克隆抗体偶联到叠氮功能化的 PAR 聚合物上来实现的。生成的 PAR 聚合物-抗 HER2/抗 CD3 抗体偶联物不仅可以特异性结合表达 HER2 和 CD3 的靶细胞,而且在非激活的人外周血单核细胞 (PBMC) 存在的情况下,对 HER2 阳性乳腺癌细胞表现出强大的细胞毒性。功能化的 PAR 聚合物为合成双特异性抗体提供了一种新策略,并可能生成具有独特药理学活性的基于 PAR 聚合物的缀合物,用于生物医学应用。

相似文献

1
Synthesis of Bispecific Antibody Conjugates Using Functionalized Poly-ADP-ribose Polymers.
Biochemistry. 2023 Mar 21;62(6):1138-1144. doi: 10.1021/acs.biochem.2c00718. Epub 2023 Feb 23.
2
A Poly-ADP-Ribose Polymer-GCSF Conjugate.
Biomacromolecules. 2022 Dec 12;23(12):5267-5272. doi: 10.1021/acs.biomac.2c01090. Epub 2022 Nov 9.
3
Generation of Bispecific Antibodies by Functionalized Poly-ADP-Ribose Polymers.
Curr Protoc. 2023 Dec;3(12):e958. doi: 10.1002/cpz1.958.
4
A poly-ADP-ribose polymer-based antibody-drug conjugate.
Chem Sci. 2020 Aug 17;11(34):9303-9308. doi: 10.1039/d0sc01795g. eCollection 2020 Sep 14.
6
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs.
Nat Rev Mol Cell Biol. 2012 Jun 20;13(7):411-24. doi: 10.1038/nrm3376.
8
Poly(ADP-ribose)--a unique natural polymer structural features, biological role and approaches to the chemical synthesis.
Nucleosides Nucleotides Nucleic Acids. 2015;34(4):258-76. doi: 10.1080/15257770.2014.984073.
10
Poly(ADP-ribose) makes a date with death.
Curr Opin Chem Biol. 2007 Dec;11(6):644-53. doi: 10.1016/j.cbpa.2007.08.038. Epub 2007 Oct 23.

引用本文的文献

1
Discovery of PARP1-Sparing Inhibitors for Protein ADP-Ribosylation.
ACS Med Chem Lett. 2024 Oct 30;15(11):1940-1946. doi: 10.1021/acsmedchemlett.4c00395. eCollection 2024 Nov 14.
2
An NAD with Dually Modified Adenine for Labeling ADP-Ribosylation-Specific Proteins.
Tetrahedron. 2024 Dec 1;168. doi: 10.1016/j.tet.2024.134361. Epub 2024 Nov 6.
3
Synthesis of site-specific Fab-drug conjugates using ADP-ribosyl cyclases.
Protein Sci. 2024 Apr;33(4):e4924. doi: 10.1002/pro.4924.
4
Generation of Bispecific Antibodies by Functionalized Poly-ADP-Ribose Polymers.
Curr Protoc. 2023 Dec;3(12):e958. doi: 10.1002/cpz1.958.
5
Rational design of humanized antibody inhibitors for cathepsin S.
Arch Biochem Biophys. 2024 Jan;751:109849. doi: 10.1016/j.abb.2023.109849. Epub 2023 Dec 5.
6
A ribose-functionalized NAD with versatile activity for ADP-ribosylation.
Chem Commun (Camb). 2023 Nov 21;59(93):13843-13846. doi: 10.1039/d3cc04343f.

本文引用的文献

1
Eliciting anti-cancer immunity by genetically engineered multifunctional exosomes.
Mol Ther. 2022 Sep 7;30(9):3066-3077. doi: 10.1016/j.ymthe.2022.06.013. Epub 2022 Jun 22.
2
Discovery of an NAD analogue with enhanced specificity for PARP1.
Chem Sci. 2022 Jan 27;13(7):1982-1991. doi: 10.1039/d1sc06256e. eCollection 2022 Feb 16.
3
Generation of bispecific antibodies using chemical conjugation methods.
Drug Discov Today Technol. 2021 Dec;40:13-24. doi: 10.1016/j.ddtec.2021.08.006. Epub 2021 Oct 20.
4
The state of the art of bispecific antibodies for treating human malignancies.
EMBO Mol Med. 2021 Sep 7;13(9):e14291. doi: 10.15252/emmm.202114291. Epub 2021 Aug 24.
5
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy.
Clin Cancer Res. 2021 Oct 15;27(20):5457-5464. doi: 10.1158/1078-0432.CCR-20-3770. Epub 2021 Jun 9.
6
A poly-ADP-ribose polymer-based antibody-drug conjugate.
Chem Sci. 2020 Aug 17;11(34):9303-9308. doi: 10.1039/d0sc01795g. eCollection 2020 Sep 14.
7
A Bifunctional NAD for Profiling Poly-ADP-Ribosylation-Dependent Interacting Proteins.
ACS Chem Biol. 2021 Feb 19;16(2):389-396. doi: 10.1021/acschembio.0c00937. Epub 2021 Feb 1.
8
T cell-engaging therapies - BiTEs and beyond.
Nat Rev Clin Oncol. 2020 Jul;17(7):418-434. doi: 10.1038/s41571-020-0347-5. Epub 2020 Apr 2.
9
Rational Design of a Humanized Antibody Inhibitor of Cathepsin B.
Biochemistry. 2020 Apr 14;59(14):1420-1427. doi: 10.1021/acs.biochem.0c00046. Epub 2020 Mar 31.
10
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy.
Mol Ther. 2020 Feb 5;28(2):536-547. doi: 10.1016/j.ymthe.2019.11.020. Epub 2019 Nov 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验